McCormick is operating through a post-acquisition integration phase while preparing to combine with Unilever Foods, aiming to build a much larger flavor and foodservice platform. The Unilever combination, operating model, and expected mid-2027 closing were already public, so this filing mainly updates the standalone business and confirms execution progress.
The quarter beat the available earnings benchmark, but not by a wide margin. Adjusted diluted EPS of $0.86 exceeded the published consensus of roughly $0.76, while net sales of $2.025 billion topped the approximately $1.98 billion expectation.
| Metric | Q3 2026 | Q3 2025 / expectation | Read |
|---|---|---|---|
| Net sales | $2,024.8 million | $1,724.9 million; ~$1.98 billion expected | 17.4% reported growth; modest revenue beat (Income Statement; Third Quarter Results) |
| Organic sales growth | 1.9% | 2026 guide: 1%–3% | Within outlook, driven by price (Sales Metrics; Fiscal Year 2026 Outlook) |
| Adjusted operating income | $358.5 million | $293.6 million | Up 22.1%; margin rose to 17.7% (Profitability Metrics) |
| Adjusted diluted EPS | $0.86 | $0.85 prior year; ~$0.76 consensus | Beat consensus; up 1.2% year over year (Profitability Metrics) |
| FY2026 adjusted EPS outlook | 2%–5% growth | Prior guide unchanged | Reaffirmed (Fiscal Year 2026 Financial Outlook) |
The quality of the operating improvement is better than the headline EPS growth suggests. Adjusted operating income rose 22% and adjusted operating margin expanded 70 basis points, helped by pricing, the McCormick de Mexico acquisition, and productivity savings. 〔0〕 The underlying sales engine remains less impressive: organic growth was only 1.9%, and Consumer volume/mix declined 1.1%, with growth largely price-led. 〔1〕
GAAP earnings were heavily distorted by transaction and impairment costs. Reported EPS fell to $0.36 from $0.84, while special charges reduced diluted EPS by $0.50; the charges included Unilever-related transaction and integration costs and a $43.1 million non-cash impairment tied to a discontinued Malaysia pepper-sourcing project. 〔2〕 That makes adjusted EPS the more useful measure for judging the quarter, but it also shows that the transformation is carrying real near-term costs.
The reaffirmed outlook is reassuring but not an upgrade. Management kept FY2026 reported sales growth at 13%–17%, organic sales growth at 1%–3%, adjusted operating income growth at 16%–20%, and adjusted EPS growth at 2%–5%. 〔3〕 With nine-month adjusted operating income up 23.8%, the company has execution cushion, but the filing does not raise the bar despite the quarterly beat.
The Unilever story advanced operationally, not strategically. Integration planning remains on track, with the future leadership team, operating model, transition agreements, and quantified Day 1 initiatives in place. 〔4〕 The transaction is still expected to close by mid-2027 subject to regulatory approvals, so the major value-creation thesis remains a future execution and financing event rather than a new development in this quarter.
Bottom line: This was a genuine earnings beat supported by much stronger margins, but the core business is still producing low-single-digit organic growth and management only reaffirmed guidance. The filing modestly improves confidence in execution without materially changing the larger Unilever-led transformation story.
Read the original 8-K on SEC EDGAR ↗